Larvol Delta - KEYNOTEE37-A-Clinical-Trial-Assessing-BT001-Alone-and-in-Combination-With-Pembrolizumab-in-Metastatic-or-Advanced-Solid-Tumors

BT-001 - BioInvent, Transgene

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT04725331

Nov 22, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next